カテゴリー： QYResearch, 世界

ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場：規模・現状・予測

◆英語タイトル：Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18221
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：97
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場について調査・分析し、ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、コンビネーション）、用途別（経口、静脈内、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界のベータラクタムおよびベータラクタマーゼ阻害剤市場動向
・主要企業別マーケットシェア
・ベータラクタムおよびベータラクタマーゼ阻害剤の種類別市場規模2014-2019
（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、コンビネーション）
・ベータラクタムおよびベータラクタマーゼ阻害剤の用途別市場規模2014-2019
（経口、静脈内、その他）
・ベータラクタムおよびベータラクタマーゼ阻害剤の北米市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤の中国市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤の日本国内市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤のインド市場：主要企業・種類別/用途別市場規模
・ベータラクタムおよびベータラクタマーゼ阻害剤の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Abbott Laboratories、Allergan Plc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Merck & Co. Inc.、Mylan N.V.、Novartis International AG (Sandoz)、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd）
・ベータラクタムおよびベータラクタマーゼ阻害剤の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Beta-lactam antibiotics are a class of antibiotics consisting of all antibiotic agents that contain a beta-lactam ring in their molecular structures. This includes penicillin derivatives, cephalosporins, monobactams, and carbapenems. These are the antimicrobial substances or compounds that fight against bacterial infections and sometimes with protozoan infections. In addition, these medications either kill the bacteria directly or stop the bacteria from growing. However, these drugs are easily available at over-the-counter (OTC) and one can buy these without a prescription in most of the countries, which leads to overuse or misuse. Thereby, bacterial resistance is developing the beta-lactam antibiotics.
In 2018, the global Beta-lactam and Beta-lactamase Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Beta-lactam and Beta-lactamase Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Beta-lactam and Beta-lactamase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Allergan Plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Mylan N.V.
Novartis International AG (Sandoz)
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd

Market segment by Type, the product can be split into
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination

Market segment by Application, split into
Oral
Intravenous
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Beta-lactam and Beta-lactamase Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Beta-lactam and Beta-lactamase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Beta-lactam and Beta-lactamase Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Penicillin
1.4.3 Cephalosporin
1.4.4 Carbapenem
1.4.5 Monobactam
1.4.6 Combination
1.5 Market by Application
1.5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2019-2025)
1.5.2 Oral
1.5.3 Intravenous
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Beta-lactam and Beta-lactamase Inhibitors Market Size
2.2 Beta-lactam and Beta-lactamase Inhibitors Growth Trends by Regions
2.2.1 Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (2019-2025)
2.2.2 Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Beta-lactam and Beta-lactamase Inhibitors Market Size by by Players
3.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by by Players (2014-2019)
3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by by Players (2014-2019)
3.1.3 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 Beta-lactam and Beta-lactamase Inhibitors Key Players Head office and Area Served
3.3 Key Players Beta-lactam and Beta-lactamase Inhibitors Product/Solution/Service
3.4 Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2014-2019)
4.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2014-2019)

5 North America
5.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
5.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in North America
5.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
5.4 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

6 Europe
6.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
6.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Europe
6.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
6.4 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

7 China
7.1 China Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
7.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in China
7.3 China Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
7.4 China Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

8 Japan
8.1 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
8.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Japan
8.3 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
8.4 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
9.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
9.4 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

10 India
10.1 India Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
10.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in India
10.3 India Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
10.4 India Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size (2014-2019)
11.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Central & South America
11.3 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
11.4 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.1.4 Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019))
12.1.5 Abbott Laboratories Recent Development
12.2 Allergan Plc.
12.2.1 Allergan Plc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.2.4 Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.2.5 Allergan Plc. Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.4.4 GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Merck & Co. Inc.
12.5.1 Merck & Co. Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.5.4 Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.5.5 Merck & Co. Inc. Recent Development
12.6 Mylan N.V.
12.6.1 Mylan N.V. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.6.4 Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.6.5 Mylan N.V. Recent Development
12.7 Novartis International AG (Sandoz)
12.7.1 Novartis International AG (Sandoz) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.7.4 Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.7.5 Novartis International AG (Sandoz) Recent Development
12.8 Pfizer Inc.
12.8.1 Pfizer Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.8.4 Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.8.5 Pfizer Inc. Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.9.4 Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.9.5 Sanofi Recent Development
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Teva Pharmaceutical Industries Ltd Company Details
12.10.2 Company Description and Business Overview
12.10.3 Beta-lactam and Beta-lactamase Inhibitors Introduction
12.10.4 Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Ltd Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Beta-lactam and Beta-lactamase Inhibitors Key Market Segments
Table Key Players Beta-lactam and Beta-lactamase Inhibitors Covered
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Penicillin Figures
Table Key Players of Penicillin
Figuer Cephalosporin Figures
Table Key Players of Cephalosporin
Figuer Carbapenem Figures
Table Key Players of Carbapenem
Figuer Monobactam Figures
Table Key Players of Monobactam
Figuer Combination Figures
Table Key Players of Combination
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application in 2018 & 2025
Figure Oral Case Studies
Figure Intravenous Case Studies
Figure Others Case Studies
Figure Beta-lactam and Beta-lactamase Inhibitors Report Years Considered
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions 2014-2019
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions 2014-2019
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Beta-lactam and Beta-lactamase Inhibitors Revenue by by Players (2014-2019) (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Share by by Players (2014-2019)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Share by by Players in 2018
Table Global Beta-lactam and Beta-lactamase Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Beta-lactam and Beta-lactamase Inhibitors Product/Solution/Service
Table Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Type (2014-2019)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size Market Share by Type (2014-2019)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Application (2014-2019)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application in 2018
Figure North America Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table North America Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table North America Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure Europe Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure China Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table China Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table China Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table China Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table China Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure Japan Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Japan Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Japan Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure India Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table India Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table India Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table India Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table India Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Figure Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2018-2019)
Table Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type 2014-2019
Table Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application 2014-2019
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Allergan Plc. Company Details
Table Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Allergan Plc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Allergan Plc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Merck & Co. Inc. Company Details
Table Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Merck & Co. Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Merck & Co. Inc. Recent Development
Table Mylan N.V. Company Details
Table Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Mylan N.V. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Mylan N.V. Recent Development
Table Novartis International AG (Sandoz) Company Details
Table Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Novartis International AG (Sandoz) Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Novartis International AG (Sandoz) Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Sanofi Recent Development
Table Teva Pharmaceutical Industries Ltd Company Details
Table Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd Recent Development
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Regions (2019-2025)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Regions in 2025
Figure North America Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Product (2019-2025)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Product in 2025
Table Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2019-2025)
Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Abbott Laboratories、Allergan Plc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Merck & Co. Inc.、Mylan N.V.、Novartis International AG (Sandoz)、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場：規模・現状・予測(Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp